co-amiloride teva 5 mg - 50 mg tabl.
teva pharma belgium sa-nv - hydrochloorthiazide 50 mg; amiloridehydrochloride 5 mg - tablet - 5 - 50 mg - hydrochloorthiazide 50 mg; amiloridehydrochloridedihydraat 5.68 mg - hydrochlorothiazide and potassium-sparing agents
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kip - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals voor aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kip - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
co-candesartan teva 16 mg - 12.5 mg tabl.
teva pharma belgium sa-nv - hydrochloorthiazide 12,5 mg; candesartancilexetil 16 mg - tablet - 16 mg - 12,5 mg - candesartancilexetil 16 mg; hydrochloorthiazide 12.5 mg - candesartan and diuretics
co-enalapril eg 20 mg - 12.5 mg tabl.
eg sa-nv - enalaprilmaleaat 20 mg; hydrochloorthiazide 12,5 mg - tablet - 20 mg - 12,5 mg - enalaprilmaleaat 20 mg; hydrochloorthiazide 12.5 mg - enalapril and diuretics
co-diovane 80 mg - 12,5 mg filmomh. tabl.
novartis pharma sa-nv - valsartan 80 mg; hydrochloorthiazide 12,5 mg - filmomhulde tablet - 80 mg - 12,5 mg - hydrochloorthiazide 12.5 mg; valsartan 80 mg - valsartan and diuretics
co-diovane 160 mg - 12,5 mg filmomh. tabl.
novartis pharma sa-nv - valsartan 160 mg; hydrochloorthiazide 12,5 mg - filmomhulde tablet - 160 mg - 12,5 mg - hydrochloorthiazide 12.5 mg; valsartan 160 mg - valsartan and diuretics
co-diovane 160 mg - 25 mg filmomh. tabl.
novartis pharma sa-nv - valsartan 160 mg; hydrochloorthiazide 25 mg - filmomhulde tablet - 160 mg - 25 mg - hydrochloorthiazide 25 mg; valsartan 160 mg - valsartan and diuretics
co-diovane 320 mg - 12,5 mg filmomh. tabl.
novartis pharma sa-nv - valsartan 320 mg; hydrochloorthiazide 12,5 mg - filmomhulde tablet - 320 mg - 12,5 mg - hydrochloorthiazide 12.5 mg; valsartan 320 mg - valsartan and diuretics